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Introduction 
Today, many countries and their peoples enjoy high standards of living, 
yet bronchitis remains a world-wide problem. Statistics show that 
bronchitis is one of the most freuqently diagnosed major disorder in 
European countries (Nairman S). Bronchitis is a cause of morbidity and 
also untold economic loss (1) in terms of loss of working days, as chronic 
bronchitis in its advanced stages is disabling, and also (2) in terms of 
social benefits such as hospitalisation and treatment. 
Definitions 
Chronic bronchitis is defined by the V.K. Research Medical Council as "a 
condition associated with excessive tracheobronchial mucus production 
sufficient to cause cough with expectoration for at least three months for 
more than two consecutive years." 
There is a general tendency to use the term chronic bronchitIs more loosely 
as a blanket term to describe the older patient with chronic cough, sputum 
production and recurrent chest infection, however, more accurate and 
scientific use of terminology should be encouraged. 
Bronchitis rarely presel)ts in isolation. It is usually accompanied by 
emphysema (pathological inflammation of the air spaces or destruction 
of the acinus), bronchial obstruction and inflammation. Often this 
spectrum is described as chonic obstructive airways disease (COAD). 
COAD is used to describe patients who have chronic bronchitis, 
emphysema or both. 
Aims 
The aims of this dissertation were: 
,. 
1. To review the definitions associated with this disease; 
2. To analyse conventional therapy and current attitudes on 
treatment; 
3. To investigate the distribution of the disease in a sample of 
Maltese patients; 
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4. to study the main bacteria found in the respiratory tracts of chronic 
bronchitics during exacerbations in a sample of Maltese patients; 
5. To compare the results. obtained from sputum culture to those 
obtained by bronchoscopic aspirations; 
6. To make recommendations on antibiotic therapy. 
Methodology 
Retrospective studies were carried out on: 
1. 107 admissions due to chronic bronchitis. The patients studied 
represent all the chronic bronchitics who were admitted under the· 
care of Dr Cacciottolo in wards M5 and M6 of St Luke's Hospital 
between January 1989 and June 1991. Re-admitted patients were 
considered as separate patients, unless otherwise stated. The 
patients' medical notes were used to obtain the data for this study. 
2. Positive cultures of all the sputa cultures of chronic bronchitics sent 
to the Microbiology Department of St Luke's Hospital for 
investigation in February and March 1991. 
3. The bacteriological results of samples obtained by bronchoscopic 
methods over a year from patiehts with lower respiratory tract 
infections. 
Results and Discussions 
1. Age 
Fig 1 shows the number of chronic bronchi tics in each age group in study 
(i) as a percentage of the general population in each age group according 
to the Demographic Review 1990 (to eliminate bias due to variations in 
the population of each age group). A clear increase in the incidence of 
chronic bronchitis with increase in age in the sample studied is observed 
(Figure 1). 
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2. Sex 
From the sample of chronic bronchitics in study (i), it was found that as 
reported by Crofton and Douglas, Fry, and also by Nairman, there is a 
marked consistant.excess in the incidence of chronic bronchitis in males. 
Table 1 
Sex 
MalL 
Female 
No. 
100 
7 
% of sample 
93.5% 
6.5% 
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Ratio 
14.3 
1.00 
3. Mortality 
There are great international variations in the death rate for bronchitis 
which may partly reflect differences in diagnostic patterns and labels. 
What is certificated as the cause of death may be somewhat arbitrary 
especially in the very old. 
According to statistics obtained from the Health Information Systems 
Unit, the total number of deaths reported to be due to chronic bronchitis 
and emphysema for the year 1990 was 35, representing 1.3% of total 
deaths. 91.4% (32) of these were males, and 8.6% (3) were females, 
amounting to 8.6% of deaths due to chronic bronchitis. The percentage of 
all deaths for 1990 reported to be caused by chronic bronchitis was 2.4% 
for males and 0.2% for females (Figure 2). 
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4. Seasonal Variations 
Most authors use mortality as an indicator of seaso·nal variations, 
although it may be argued that mortality statistics are an inadequate 
index of the frequency and distribution of this disease. 
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Figure 2 shows clearly that in fact in Malta there is a higher mortality 
rate in the winter months, from January to March, which agrees with the 
observations made by Crofton and Douglas. 
A higher incidence of chronic bronchitis in the winter months is also 
indicated when considering the number of hospital bed-days per quarter 
occupied by the sample surveyed in study (i) (Figure 3). 
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5. Effect of Smoking 
The correlation between smoking and incidence of chronic bronchitis has 
been studied by Fry, who found that the incidence of chronic bronchitis in 
the general population is higher amongst smokers. In a study on males it 
was observed 46% of those suffering from chronic bronchitis were smokers, 
38.5% were ex-smokers and 15.55% had never smoked. 
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If one had to consider the males only out of the sample in study (i), a 
similar trend is observed. One would find that 48% were smokers, 43% 
were ex-smokers and 9% had never smoked. 
6. Locality 
The area of residence of each different patient was noted and coded into 
six districts as in the Demographic Review. The figures obtained were 
reported as per 100,000 of population in the district. In fact it was found 
that the highest incidence of chronic bronchitics from this sample 
occurred in District I, the Inner Harbour Region, in which a Power Station 
is located as well as the Malta Drydocks, both of which may be 
implicated in atmospheric pollution. District 1 also includes the major 
town, through which there is a large daily passage of traffic: hence 
higher amount of car exhaust are also to be expected in the towns and 
villages within this district than in other districts, which doubtlessly 
contributes to the higher incidence of the condition in this district 
(Figure 4). It must be noted that in this survey, re-admissions were not 
considered. 
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7. Treatment 
Obtaining samples for microbiological investigation by bronchoscopy 
reduces the risk of contamination of the sample, as the sample is obtained 
directly from the lower respiratory tract unlike sputa samples which 
may become contaminated by organisms in the upper respiratory tract. In 
fact it was seen that the results obtained from testing of sputa samples 
are quite reliable as the results compare quite well to those obtained from 
bronchoscopic aspirations. It was also observed from both study (ii) and 
also study (lii) that the main bacteria found in the respiratory tract of 
patients with exacerbations of chronic bronchitis are Beta-haemolytic 
streptococci, H. parainJluemae and H. inJluenzae. 
Sensitivity testing shows that ampicillin and tetracydines are the best 
choice as first-line treatment. The relatively low incidence of the other 
organisms found in comparison to the above mentioned three leads one to 
suspect that most of these may be hospital-acquired. In cases where 
ampicillin and tetracydines are not effective, davulanate-potentiated 
amoxyciUin or cephalosporins should be used. Co-trimoxazole is not 
recommended due to a high degree of resistance to both its components, 
probably resulting from over-prescription of the drug. It is worth noting 
that in those cases where an antibiotic was prescribed before the results 
of sensitivity testing performed on the sputa samples surveyed were 
available, 38.2% of the antibiotics prescribed were ineffective because 
one of the organism in' question was found to be resistant to that 
particular antibiotic. This indicates the advisability of prescribing 
antibiotics on microbiological guidance. 
The following rest.Ilts were obtained: 
Table 2 
Cases where a single organism was reported 80 
Cases where multiple organisms were reported 96 
Frequency of occurrence of each organism: (Percentages are of all 
organisms found). 
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Frequency of occurrence of each organism: (Percentages are of all 
organisms found). 
Table 3 
Sputa Key Bronchoscop 
Beta-Haemolytic streptococcus 128 44.4% A 23 46.0% 
Haemophilus influenzae 32 11.1% B 5 10.0% 
Haemophilus parainfluenzae 60 20.8% C 11 22.0% 
Enterobactericae 20 6.9% D 3 6.0% 
Pseudomonas aeruginosa 16 5.6% E 2 4.0% 
Acinetobacter anitratus 8 2.8% F 2 4.0% 
Streptococcus pneumoniae 12 4.2% G 2 4.0% 
Staphylococcus aureus 12 4.2% H 2 4.0% 
Conclusions and Recommendations 
The conclusions and recommendations that can be drawn from the patients 
studied in survey (i) are basically the following: 
1. The incidence of chronic bronchitis increases with age; 
2. Chronic bronchitis afflicts mainly the male population; 
3. Exacerbations are most frequent and severe in the months of 
January, February and March; 
4. Most chronic bronchitics are or were smokers: early prevention by 
educating the patient as well as helping smokers to rid themselves 
of their habit may be important steps in the control of this 
condition. 
From studies (iD and (iii) the following conclusions and recommendations 
can be made: 
1. The three most frequently found bacteria in the respiratory tract of 
patients withexacerbations of chronic bronchitis are (i) Beta-
haemolytic streptococci; (ii) Haemophilus parainfluenzae and 
(iii) Haemophilus influenzae; 
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2. Sputa samples are quite reliable samples on which to carry out 
microbiological investigations; contamination does not appear to 
be a major problem; 
3. It is recommended that in infectious episodes, the facilities at the 
microbiological department be utilised fully and the guidance 
offered should be made use of when prescribing an antibiotic; 
4. When results of microbiological investigations are not avilable, 
ampicillin and tetracycline are good choices as first-line 
antibiotics, whereas in cases where these are ineffective, 
clavulanatc-potentiated amoxycillin or cephalosporins are 
recommended as second-l"~lle treatment. 
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